SCHEMBL6693532

SCHEMBL6693532

CC(C=Cc1ccc(O)cc1)(C(=O)O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.52
CA1 P00915 4/20 0.52
CA2 P00918 4/20 0.52
CA7 P43166 4/20 0.52
CA9 Q16790 4/20 0.52
CA14 Q9ULX7 4/20 0.52
TYR P14679 3/20 0.52
AKR1B10 O60218 3/20 0.52
AKR1B1 P15121 3/20 0.52
PKM P14618 2/20 0.52
ESR1 P03372 1/20 0.52
CA3 P07451 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
DPP4 P27487 1/20 0.52
CA5A P35218 1/20 0.52
HCAR2 Q8TDS4 1/20 0.52
ESR2 Q92731 1/20 0.52
CA5B Q9Y2D0 1/20 0.52
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6067666 0.84 CYP2C19 (0.67) HCAR2CYP2C19F3CYP2D6CYP2C9
SCHEMBL6067715 0.81 CYP2C19 (0.54) CA1CYP2C19CYP2C9RAB9AKMT2A
SCHEMBL3508677 0.80 THRB (0.59) CYP2C19F3GSK3BBACE1RAB9A
SCHEMBL8736402 0.79 LCK (0.50) CYP2C19MAOBMAOA
SCHEMBL11032283 0.77 APP (0.52) CA12CA1CA2CA7CA9
SCHEMBL2600069 0.77 APP (0.52) CA12CA1CA2CA7CA9
SCHEMBL31351505 0.73 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL14305416 0.73 TYR (0.44) CA12CA1CA2CA7CA9
SCHEMBL29484744 0.72 HIF1A (0.53) CA12CA1CA2CA7CA9
SCHEMBL11049215 0.72 CYP3A4 (0.48) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004113266-A1 DERIVATIVES OF PHENYLALKYL AND PHENOXYALKYL ACIDS FOR THE TREATMENT OF THE HYPERGLYCAEMIA AND HYPERTRIGLYCERIDAEMIA AND TYPE 2 DIABETES AND PROCESS FOR PREPARING THEM SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-12-29 WO disclosed